InterventionsReview
SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Managing Metabolic Syndrome Among Patients with Type 2 Diabetes Mellitus - A Narrative Review
Cardiovascular & Hematological Disorders Drug Targets
- GLP-1 receptor agonists
- SGLT2 inhibitors
- GLP-1 and incretin signalling
- Metabolic syndrome
- Type 2 diabetes
- Humans
The paper
Hadeeqah Zayaan Riaz Ahamed, Sulthan Al Rashid, Rajkapoor Balasubramanian, Naina Mohamed Pakkir Maideen
Cairo University · Dubai Health Authority
Cardiovascular & Hematological Disorders Drug Targets · 2 Sep 2026